188 related articles for article (PubMed ID: 30934606)
1. Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome.
Wang SY; Wu CE; Lai CC; Chen JS; Tsai CY; Cheng CT; Yeh TS; Yeh CN
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30934606
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.
Rutkowski P; Gronchi A; Hohenberger P; Bonvalot S; Schöffski P; Bauer S; Fumagalli E; Nyckowski P; Nguyen BP; Kerst JM; Fiore M; Bylina E; Hoiczyk M; Cats A; Casali PG; Le Cesne A; Treckmann J; Stoeckle E; de Wilt JH; Sleijfer S; Tielen R; van der Graaf W; Verhoef C; van Coevorden F
Ann Surg Oncol; 2013 Sep; 20(9):2937-43. PubMed ID: 23760587
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors.
Seshadri RA; Rajendranath R
J Cancer Res Ther; 2009; 5(4):267-71. PubMed ID: 20160360
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors of the stomach: report of three cases.
Oh JS; Lee JL; Kim MJ; Ryu MH; Chang HM; Kim TW; Jang SJ; Yook JH; Oh ST; Kim BS; Kang YK
Cancer Res Treat; 2006; 38(3):178-83. PubMed ID: 19771279
[TBL] [Abstract][Full Text] [Related]
5. Preservation of Organ Function in Locally Advanced Non-Metastatic Gastrointestinal Stromal Tumors (GIST) of the Stomach by Neoadjuvant Imatinib Therapy.
Vassos N; Jakob J; Kähler G; Reichardt P; Marx A; Dimitrakopoulou-Strauss A; Rathmann N; Wardelmann E; Hohenberger P
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33546113
[TBL] [Abstract][Full Text] [Related]
6. Organ-preserving surgery for locally advanced duodenal gastrointestinal stromal tumor after neoadjuvant treatment.
Lv A; Qian H; Qiu H; Wu J; Li Y; Li Z; Hao C
Biosci Trends; 2017 Sep; 11(4):483-489. PubMed ID: 28845017
[TBL] [Abstract][Full Text] [Related]
7. Multimodality therapy of rectal gastrointestinal stromal tumors in the era of imatinib-an Indian series.
Pai VD; Demenezes JL; Patil PS; Saklani AP
J Gastrointest Oncol; 2016 Apr; 7(2):262-8. PubMed ID: 27034795
[TBL] [Abstract][Full Text] [Related]
8. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
Andtbacka RH; Ng CS; Scaife CL; Cormier JN; Hunt KK; Pisters PW; Pollock RE; Benjamin RS; Burgess MA; Chen LL; Trent J; Patel SR; Raymond K; Feig BW
Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic resection of locally advanced gastrointestinal stromal tumour (GIST) of the stomach following neoadjuvant imatinib chemoreduction.
Berney CR
Int J Surg Case Rep; 2015; 8C():103-6. PubMed ID: 25651537
[TBL] [Abstract][Full Text] [Related]
10. Is surgery mandatory in locally advanced gastrointestinal stromal tumors after imatinib? A case report and literature review.
Rossi S; Congedo T; Ricci R; Martini M; Di Noia V; Di Dio C; Quirino M; Barone C; Cassano A
J Gastrointest Oncol; 2017 Feb; 8(1):E4-E9. PubMed ID: 28280629
[TBL] [Abstract][Full Text] [Related]
11. Rectal GIST-Outcomes and viewpoint from a tertiary cancer center.
Zanwar S; Ostwal V; Sahu A; Jain D; Ramaswamy A; Saklani A; Ramadwar M; Shetty N; Shrikande SV
Indian J Gastroenterol; 2016 Nov; 35(6):445-449. PubMed ID: 27783353
[TBL] [Abstract][Full Text] [Related]
12. The Outcome of Neoadjuvant Imatinib Therapy Combined With Surgery for Rectal Gastrointestinal Stromal Tumors: A Report of Three Cases and a Review of the Literature.
Ramdani A; Bouhout T; Serji B; Khannoussi W; El Harroudi T
Cureus; 2020 Dec; 12(12):e12100. PubMed ID: 33489517
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant imatinib: longer the better, need to modify risk stratification for adjuvant imatinib.
Ramaswamy A; Jain D; Sahu A; Ghosh J; Prasad P; Deodhar K; Shetty N; Banavali S; Shrikhande S; Ostwal V
J Gastrointest Oncol; 2016 Aug; 7(4):624-31. PubMed ID: 27563454
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of neoadjuvant imatinib therapy for patients with locally advanced rectal gastrointestinal stromal tumors: A multi-center cohort study.
Li W; Li X; Yu K; Xiao B; Peng J; Zhang R; Zhang L; Wang K; Pan Z; Li C; Wu X
Front Pharmacol; 2022; 13():950101. PubMed ID: 36238544
[No Abstract] [Full Text] [Related]
15. Pathologic Complete Response in a Large Gastric GIST: Using Molecular Markers to Achieve Maximal Response to Neoadjuvant Imatinib.
Brown JB; Pai RK; Burgess MA; Chennat J; Zureikat AH
J Natl Compr Canc Netw; 2018 Dec; 16(12):1424-1428. PubMed ID: 30545989
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of imatinib mesylate neoadjuvant treatment for a locally advanced rectal gastrointestinal stromal tumor.
Yoon KJ; Kim NK; Lee KY; Min BS; Hur H; Kang J; Lee S
J Korean Soc Coloproctol; 2011 Jun; 27(3):147-52. PubMed ID: 21829770
[TBL] [Abstract][Full Text] [Related]
17. A systematic review and meta-analysis of neoadjuvant imatinib use in locally advanced and metastatic gastrointestinal stromal tumors.
Lam TJR; Udonwa SA; Masuda Y; Yeo MHX; Farid Bin Harunal Ras M; Goh BKP
World J Surg; 2024 May; ():. PubMed ID: 38757916
[TBL] [Abstract][Full Text] [Related]
18. Radiologic assessment of earliest, best, and plateau response of gastrointestinal stromal tumors to neoadjuvant imatinib prior to successful surgical resection.
Tirumani SH; Shinagare AB; Jagannathan JP; Krajewski KM; Ramaiya NH; Raut CP
Eur J Surg Oncol; 2014 Apr; 40(4):420-8. PubMed ID: 24238762
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib.
Tielen R; Verhoef C; van Coevorden F; Gelderblom H; Sleijfer S; Hartgrink HH; Bonenkamp JJ; van der Graaf WT; de Wilt JH
Eur J Surg Oncol; 2013 Feb; 39(2):150-5. PubMed ID: 23084087
[TBL] [Abstract][Full Text] [Related]
20. Excision of a Large Gastrointestinal Stromal Tumour Following 16 Months of Neoadjuvant Therapy with Imatinib (Case Report).
Alassani F; Tchangai B; Bagny A; Adani-Ife AA; Amavi KA; Darre T; Attipou K
Oncol Ther; 2019 Dec; 7(2):159-164. PubMed ID: 32699986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
